2017
DOI: 10.4314/tjpr.v16i9.14
|View full text |Cite
|
Sign up to set email alerts
|

Chemopreventive properties of curcumin analogues, hexagamavunone-0 and gamavutone-0, in rat colorectal cancer model

Abstract: Purpose: To examine the chemopreventive activity of curcumin analogues, hexagamavunone-0 (HGV-0) and gamavutone-0 (GVT-0), compared to curcumin in a colorectal cancer model in Wistar rats. Methods: Rats (n = 25) were assigned to one of five groups (n = 5 in each group). Colorectal cancer was induced in the control group with subcutaneous injection of 1,2-dimethylhydrazine (DMH) 60 mg/kg once a week for 15 weeks. In addition to DMH injection, treatment groups were treated with curcumin (20, 40, or 80 mg/kg),20,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2
2
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…Formerly, PGV-1 has been shown anti-tumorigenic activities against leukemia and breast cancer in xenograft mice model [6, 7], but has not been explored in colorectal cancer. While the other curcumin analogs, pentagamavunone-0 (PGV-0), gamavutone-0 (GVT-0), and hexagamavunone-0 (HGV-0), exhibited anti-in ammatory activity in the DMH-colorectal cancer rat model [12]. In this regard, we challenge and continue to explore PGV-1 and CCA-1.1, a targeted and selective candidate for colorectal cancer chemotherapeutic agents through in vitro, in vivo, and bioinformatic exploration.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Formerly, PGV-1 has been shown anti-tumorigenic activities against leukemia and breast cancer in xenograft mice model [6, 7], but has not been explored in colorectal cancer. While the other curcumin analogs, pentagamavunone-0 (PGV-0), gamavutone-0 (GVT-0), and hexagamavunone-0 (HGV-0), exhibited anti-in ammatory activity in the DMH-colorectal cancer rat model [12]. In this regard, we challenge and continue to explore PGV-1 and CCA-1.1, a targeted and selective candidate for colorectal cancer chemotherapeutic agents through in vitro, in vivo, and bioinformatic exploration.…”
Section: Discussionmentioning
confidence: 99%
“…Red blood count (RBC) and white blood count (WBC) [6] were measured using the Automatic Hematology Analyzer Sysmex KX-21. The nodules were recorded for analysis using equation 1 [12]. where VN = volume of nodules, NL = nodule length, NW = nodule width.…”
Section: Animals and Treatment Schedulesmentioning
confidence: 99%